Literature DB >> 31292924

Macrolides or fluoroquinolones as enteral antibiotic therapy for non-ICU legionellosis.

Renaud Scussel1, Karine Risso2, Elisa Demonchy2, Céline Michelangeli2, Pierre-Marie Roger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31292924     DOI： 10.1007/s15010-019-01340-3

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  3 in total

1.  Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis.

Authors:  C Garcia-Vidal; I Sanchez-Rodriguez; A F Simonetti; J Burgos; D Viasus; M T Martin; V Falco; J Carratalà
Journal:  Clin Microbiol Infect       Date:  2017-03-06       Impact factor: 8.067

Review 2.  Medical table: A major tool for antimicrobial stewardship policy.

Authors:  P-M Roger; E Demonchy; K Risso; J Courjon; S Leroux; E Leroux; É Cua
Journal:  Med Mal Infect       Date:  2017-04-28       Impact factor: 2.152

Review 3.  Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.

Authors:  C Burdet; R Lepeule; X Duval; M Caseris; C Rioux; J-C Lucet; Y Yazdanpanah
Journal:  J Antimicrob Chemother       Date:  2014-05-14       Impact factor: 5.790
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.